Physician profile
Robert A Gaertner
NPI 1942297171
$1,219.34
in general payments reported to CMS, 2019-2025
12 companies · $44.89 in 2025
The $44.89 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2021: $99.51 · 2022: $137 · 2023: $675 · 2025: $44.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678 · Gift: $22.84 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.05 |
| Gift | $22.84 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $631.98 | 2019-2023 | Da Vinci Surgical System |
| Dendreon Pharmaceuticals LLC | $162.71 | 2019 | |
| Coloplast Corp | $85.40 | 2021 | |
| Astellas Pharma US INC | $76.62 | 2019 | |
| Progenics Pharmaceuticals, INC. | $57.50 | 2022-2023 | Pylarify |
| Boston Scientific Corporation | $44.89 | 2025 | Axonics |
| Convatec INC. | $41.47 | 2021-2022 | |
| Srs Medical Systems, INC. | $40.25 | 2022 | |
| Merck Sharp & Dohme LLC | $31.49 | 2022-2023 | Lynparza, Keytruda |
| Janssen Biotech, INC. | $16.83 | 2023 | Erleada |
| Antares Pharma, INC. | $16.35 | 2022 | |
| Hollister Incorporated | $13.85 | 2023 | Vapro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gaertner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.